TNF-α inhibitors have been shown to be associated with a lower risk of dementia in patients with rheumatoid arthritis and animal studies, but there are concerns of adverse events and the blocking physiological role of TNF-α through TNFR2 [63,64]. The gene discussed is TNFRSF1B; the disease is rheumatoid arthritis.